BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere's INRatio
Oct 11 U.S. FDA:
* Analyses conclude that Xarelto clinical trial results were not affected by Alere's faulty monitoring device INRatio
* FDA concludes blood thinner drug Xarelto is a safe and effective alternative to warfarin in patients with atrial fibrillation Source text bit.ly/2e3iYqp Further company coverage:
One dead in ENI Congo oil platform fire
BRAZZAVILLE, Dec 3 One person was killed in a fire on an oil platform operated by ENI Congo off the coast of the Congo Republic city of Pointe-Noire, the government said.
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.